Home About us Contact
|
Home About us Contact | ||
|
|
||
Plasma Analysis (plasma + analysis)
Selected AbstractsAmperometric Sensor for Heparin: Sensing Mechanism and Application in Human Blood Plasma AnalysisELECTROANALYSIS, Issue 13-14 2006Jan Langmaier Abstract Voltammetric measurements of heparin at a rotating glassy carbon (GC) electrode coated with a polyvinylchloride membrane are reported. A spin-coating technique is used to prepare thin membranes (20,40,,m) with a composition of 25% (w/w) PVC, 1,1,-dimethylferrocene as a reference electron donor for the GC|membrane interface, nitrophenyl octyl ether (o -NPOE) or bis(2-ethylhexyl) sebacate (DOS) as a plasticizer, and hexadecyltrimethylammonium tetrakis(4-chlorophenyl) borate (HTMATPBCl) or tridodecylmethylammonium tetrakis(4-chlorophenyl) borate (TDMATPBCl) as a background electrolyte. It is shown that the electrodes coated with either the HTMA+/o -NPOE (DOS) or TDMA+/o -NPOE (DOS) membrane provide a comparable amperometric response towards heparin (1,10,U mL,1) in the aqueous solution of 0.1,M LiCl. However, only the membranes formulated with TDMATPBCl can be used for an amperometric assay of heparin in human blood plasma with a detection limit of 0.2,U mL,1. Effects of membrane composition, heparin concentration, rotation speed and sweep rate on the voltammetric behavior of heparin provide some insight into the sensing mechanism. Theoretical analysis of the amperometric response is outlined, and the numeric simulation of the voltammetric behavior is presented. [source] Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniquesRAPID COMMUNICATIONS IN MASS SPECTROMETRY, Issue 2 2009Marinella De Leo Tramadol is a centrally acting analgesic drug that has been used clinically for the last two decades to treat pain in humans. The clinical response of tramadol is strictly correlated to its metabolism, because of the different analgesic activity of its metabolites. O -Desmethyltramadol (M1), its major active metabolite, is 200 times more potent at the µ -receptor than the parent drug. In recent years tramadol has been widely introduced in veterinary medicine but its use has been questioned in some species. The aim of the present study was to develop a new sensible method to detect the whole metabolic profile of the drug in horses, through plasma analyses by high-performance liquid chromatography (HPLC) coupled with fluorimetric (FL) and photodiode array electrospray ionization mass spectrometric (PDA-ESI-MS) detection, after its sustained release by oral administration (5,mg/kg). In HPLC/FL experiments the comparison of the horse plasma chromatogram profile with that of a standard mixture suggested the identification of the major peaks as tramadol and its metabolites M1 and N,O -desmethyltramadol (M5). LC/PDA-ESI-MS/MS analysis confirmed the results obtained by HPLC/FL and also provided the identification of two more metabolites, N -desmethyltramadol (M2), and N,N -didesmethyltramadol (M3). Another metabolite, M6, was also detected and identified. The present findings demonstrate the usefulness and the advantage of LC/ESI-MS/MS techniques in a search for tramadol metabolites in horse plasma samples. Copyright © 2008 John Wiley & Sons, Ltd. [source] Use of average value of Langmuir probe characteristic for characterization of pulsed dischargesCONTRIBUTIONS TO PLASMA PHYSICS, Issue 7 2003J. Bla Abstract Based on numerical calculations a new method has been developed, which enables plasma analysis from the average value of the Langmuir probe current measured in pulsed discharge. The application of this method for characterization of a planar reactor used for plasma enhanced chemical vapor deposition of TiN and (TiAl)N hard coatings is described as an example. (© 2003 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) [source] New aspects concerning ulcerative colitis and colonic carcinoma: Analysis of levels of neuropeptides, neurotrophins, and TNFalpha/TNFreceptor in plasma and mucosa in parallel with histological evaluation of the intestineINFLAMMATORY BOWEL DISEASES, Issue 10 2008Malin Johansson MSc Abstract Background: The levels of neuropeptides, neurotrophins, and TNFalpha (TNF,)/TNF receptor in plasma and mucosa for patients with ulcerative colitis (UC) and colonic carcinoma, and concerning plasma also for healthy controls, were examined. Moreover, the relationships between the different substances and the influence of mucosal derangement on the levels were analyzed. Methods: The levels of VIP, SP, CGRP, BDNF, NGF, and TNF,/TNFreceptor1 were measured using ELISA/EIA. Results: Patients with UC demonstrated the highest levels of all analyzed substances in plasma, with the exception of BDNF. However, there were differences within the UC group, patients treated with corticosteroids, and/or nonsteroid antiinflammatory/immunosuppressive treatment having higher plasma levels than those not given these treatments. Patients with colonic carcinoma showed higher SP and TNFreceptor1 levels in plasma compared to healthy controls. Concerning mucosa, the levels of almost all analyzed substances were elevated for patients with UC compared to noncancerous mucosa of colonic carcinoma patients. There were correlations between many of the substances in both plasma and mucosa, especially concerning the 3 neuropeptides examined. There were also marked associations with mucosa derangement. Conclusions: Via analysis of correlations for the respective patients and via comparisons between the different patient groups, new and original information was obtained. Interestingly, the degree of mucosal affection was markedly correlated with tissue levels of the substances and the treatments were found to be of importance concerning plasma but not tissue levels of these. Combined plasma analysis of neuropeptides, neurotrophins, and TNFreceptor1 may help to distinguish UC and colonic carcinoma patients. (Inflamm Bowel Dis 2008) [source] The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study,JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Issue 1 2003N. F. Dowling Summary., The aim of this study was to assess, comprehensively, medical and genetic attributes of venous thromboembolism (VTE) in a multiracial American population. The Genetic Attributes and Thrombosis Epidemiology (GATE) study is an ongoing case,control study in Atlanta, Georgia, designed to examine racial differences in VTE etiology and pathogenesis. Between 1998 and 2001, 370 inpatients with confirmed VTE, and 250 control subjects were enrolled. Data collected included blood specimens for DNA and plasma analysis and a medical lifestyle history questionnaire. Comparing VTE cases, cancer, recent surgery, and immobilization were more common in caucasian cases, while hypertension, diabetes, and kidney disease were more prevalent in African-American cases. Family history of VTE was reported with equal frequency by cases of both races (28,29%). Race-adjusted odds ratios for the associations of factor V Leiden and prothrombin G20210A mutations were 3.1 (1.5, 6.7) and 1.9 (0.8, 4.4), respectively. Using a larger external comparison group, the odds ratio for the prothrombin mutation among Caucasians was a statistically significant 2.5 (1.4, 4.3). A case-only analysis revealed a near significant interaction between the two mutations among Caucasians. We found that clinical characteristics of VTE patients differed across race groups. Family history of VTE was common in white and black patients, yet known genetic risk factors for VTE are rare in African-American populations. Our findings underscore the need to determine gene polymorphisms associated with VTE in African-Americans. [source] High sensitivity determination of valproic acid in mouse plasma using semi-automated sample preparation and liquid chromatography with tandem mass spectrometric detectionRAPID COMMUNICATIONS IN MASS SPECTROMETRY, Issue 24 2005Vincenzo Pucci A high-throughput liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) assay using automated sample preparation has been developed for the determination of valproic acid (VPA) in mouse plasma. A liquid-handling system was programmed to prepare calibration standard solutions in plasma, as well as quality controls and clinical samples. Plasma protein precipitation was performed on a 96-well plate, and the collected supernatant was directly injected into a reversed-phase LC/ESI-MS/MS system in the negative ionization mode. The calibration curve for VPA was linear over a dynamic range of 0.15,100,µg/mL. The limit of detection was 75,ng/mL and the lower limit of quantitation was 150,ng/mL. Intra- and inter-day validation assays of the semi-automated plasma analysis showed satisfactory accuracy and precision. Copyright © 2005 John Wiley & Sons, Ltd. [source] A novel on-line solid-phase extraction approach integrated with a monolithic column and tandem mass spectrometry for direct plasma analysis of multiple drugs and metabolitesRAPID COMMUNICATIONS IN MASS SPECTROMETRY, Issue 22 2005Xu Zang An on-line solid-phase extraction liquid chromatography/tandem mass spectrometry (SPE LC/MS/MS) assay using a newly developed SPE column and a monolithic column was developed and validated for direct analysis of plasma samples containing multiple analytes. This assay was developed in an effort to increase bioanalysis throughput and reduce the complexity of on-line SPE LC/MS/MS systems. A simple column-switching configuration that requires only one six-port valve and one HPLC pumping system was employed for on-line plasma sample preparation and subsequent gradient chromatographic separation. The resulting analytical method couples the desired sensitivity with ease of use. The method was found to perform satisfactorily for direct plasma analysis with respect to assay linearity, specificity, sensitivity, precision, accuracy, carryover, and short-term stability of an eight-analyte mixture in plasma. A gradient LC condition was applied to separate the eight analytes that cannot be distinctly differentiated by MS/MS. With a run time for every injection of 2.8,min, a minimum of 300 direct plasma injections were made on one on-line SPE column without noticeable changes in system performance. Due to the ruggedness and simplicity of this system, generic methods can be easily developed and applied to analyze a wide variety of compounds in a high-throughput manner without laborious off-line sample preparation. Copyright © 2005 John Wiley & Sons, Ltd. [source] | |||||||||||||